Your browser doesn't support javascript.
loading
LIN28 cooperates with WNT signaling to drive invasive intestinal and colorectal adenocarcinoma in mice and humans.
Tu, Ho-Chou; Schwitalla, Sarah; Qian, Zhirong; LaPier, Grace S; Yermalovich, Alena; Ku, Yuan-Chieh; Chen, Shann-Ching; Viswanathan, Srinivas R; Zhu, Hao; Nishihara, Reiko; Inamura, Kentaro; Kim, Sun A; Morikawa, Teppei; Mima, Kosuke; Sukawa, Yasutaka; Yang, Juhong; Meredith, Gavin; Fuchs, Charles S; Ogino, Shuji; Daley, George Q.
Afiliação
  • Tu HC; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts 02115, USA; Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA; Harvard Stem Cell Institute, Boston, Massachusetts 02115, USA;
  • Schwitalla S; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts 02115, USA; Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA; Harvard Stem Cell Institute, Boston, Massachusetts 02115, USA;
  • Qian Z; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA;
  • LaPier GS; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts 02115, USA; Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA; Harvard Stem Cell Institute, Boston, Massachusetts 02115, USA;
  • Yermalovich A; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts 02115, USA; Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA; Harvard Stem Cell Institute, Boston, Massachusetts 02115, USA;
  • Ku YC; Thermo Fisher Scientific, Incorporated, South San Francisco, California 94080, USA;
  • Chen SC; Thermo Fisher Scientific, Incorporated, South San Francisco, California 94080, USA;
  • Viswanathan SR; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts 02115, USA; Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA; Harvard Stem Cell Institute, Boston, Massachusetts 02115, USA;
  • Zhu H; Children's Medical Center Research Institute, University of Texas Southwestern, Dallas, Texas 75390, USA;
  • Nishihara R; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA;
  • Inamura K; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA;
  • Kim SA; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA;
  • Morikawa T; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA;
  • Mima K; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA;
  • Sukawa Y; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA;
  • Yang J; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA;
  • Meredith G; Thermo Fisher Scientific, Incorporated, South San Francisco, California 94080, USA;
  • Fuchs CS; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA;
  • Ogino S; Department of Medical Oncology, Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA; Harvard Medical School, Boston, Massachusetts 02115, USA; Department of Epidemiology, Harvard School of Public Heal
  • Daley GQ; Division of Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts 02115, USA; Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA; Harvard Stem Cell Institute, Boston, Massachusetts 02115, USA; Howard Hughes Medical Institute, Boston, Massachusetts 02138, USA ge
Genes Dev ; 29(10): 1074-86, 2015 May 15.
Article em En | MEDLINE | ID: mdl-25956904
ABSTRACT
Colorectal cancer (CRC) remains a major contributor to cancer-related mortality. LIN28A and LIN28B are highly related RNA-binding protein paralogs that regulate biogenesis of let-7 microRNAs and influence development, metabolism, tissue regeneration, and oncogenesis. Here we demonstrate that overexpression of either LIN28 paralog cooperates with the Wnt pathway to promote invasive intestinal adenocarcinoma in murine models. When LIN28 alone is induced genetically, half of the resulting tumors harbor Ctnnb1 (ß-catenin) mutation. When overexpressed in Apc(Min/+) mice, LIN28 accelerates tumor formation and enhances proliferation and invasiveness. In conditional genetic models, enforced expression of a LIN28-resistant form of the let-7 microRNA reduces LIN28-induced tumor burden, while silencing of LIN28 expression reduces tumor volume and increases tumor differentiation, indicating that LIN28 contributes to tumor maintenance. We detected aberrant expression of LIN28A and/or LIN28B in 38% of a large series of human CRC samples (n = 595), where LIN28 expression levels were associated with invasive tumor growth. Our late-stage CRC murine models and analysis of primary human tumors demonstrate prominent roles for both LIN28 paralogs in promoting CRC growth and progression and implicate the LIN28/let-7 pathway as a therapeutic target.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Adenocarcinoma / Transdução de Sinais / Proteínas de Ligação a RNA / Proteínas Wnt Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Genes Dev Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Adenocarcinoma / Transdução de Sinais / Proteínas de Ligação a RNA / Proteínas Wnt Tipo de estudo: Prognostic_studies Limite: Animals / Humans Idioma: En Revista: Genes Dev Assunto da revista: BIOLOGIA MOLECULAR Ano de publicação: 2015 Tipo de documento: Article